Does evidence support supervised injection sites?

Jennifer Ng, Christy Sutherland, Michael R. Kolber (2017)

Clinical question: Do supervised injection sites (SISs) reduce mortality,
hospitalizations, ambulance calls, or disease.
Bottom line: Best evidence from cohort and modeling studies suggests that SISs are associated with lower overdose mortality (88 fewer overdose deaths per 100 000 person-years [PYs]), 67% fewer ambulance calls for treating overdoses, and a decrease in HIV infections. Effects on hospitalizations are unknown.

Does evidence support supervised injection sites?

Does evidence support supervised injection sites? (372)

Website
English
In partnership with:
ISFF
FUAS
Correlation Network